Prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome.
OBJECTIVE
To test if serially sampled determinations of the contact system proteins and factor V have prognostic value for death in patients who develop the systemic inflammatory response syndrome.


METHODS
Prospective, observational study with sequential measurements in an inception cohort.


METHODS
Medical intensive care unit (ICU) in a community hospital.


METHODS
Over a 1-yr period, a population base sample of 23 patients was selected from all ICU admissions who met established criteria for the systemic inflammatory response syndrome.


METHODS
None.


RESULTS
Components of the contact system, factor XII, prekallikrein, high-molecular-weight kininogen, factor XI, alpha 2-macroglobulin-kallikrein complexes and factor V values were measured in plasma samples collected serially (day of admission, and at 2, 12, 24, 48 and/or 72 hrs or at discharge). Data were analyzed to determine if admission values or serially obtained values within 48 hrs were useful in predicting outcome. Fourteen patients survived and nine died. At admission, in all patients, assay values indicated that prekallikrein, high-molecular-weight kininogen, and factor V were significantly lower than normal (as observed in a range of 20 to 23 healthy adults), alpha 2-macroglobulin-kallikrein complexes were higher than normal, while concentrations of factor XII and factor XI were in the normal range. No differences were detected in the admission values between survivors and nonsurvivors, nor between patients with positive or negative blood cultures. However, subsequent values demonstrated a difference in values between survivors and nonsurvivors. Survivors showed improvement in high molecular weight kininogen values and higher than normal factor V values, as compared with nonsurvivors.


CONCLUSIONS
Low or persistently low serial factor XII, high-molecular-weight kininogen and factor V values are associated with a poor prognosis, whereas high or increasing values of factor XII, high-molecular-weight kininogen, prekallikrein, and factor V all correlate with a favorable outcome.
Pixley
R A
RA
Abington Memorial Hospital, PA.
Zellis
S
S
Bankes
P
P
DeLa Cadena
R A
RA
Page
J D
JD
Scott
C F
CF
Kappelmayer
J
J
Wyshock
E G
EG
Kelly
J J
JJ
Colman
R W
RW
D000368:Aged; D001777:Blood Coagulation; D005165:Factor V / Q000032:analysis*; D005172:Factor XI / Q000032:analysis; D005174:Factor XII / Q000032:analysis; D006801:Humans; D007704:Kininogens / Q000097:blood; D011288:Prekallikrein / Q000032:analysis; D011379:Prognosis; D011446:Prospective Studies; D017741:Survivors; D018746:Systemic Inflammatory Response Syndrome / Q000097:blood* / Q000401:mortality; D000511:alpha-Macroglobulins / Q000032:analysis
D007704:Kininogens; D000511:alpha-Macroglobulins; D005165:Factor V; D005174:Factor XII; D005172:Factor XI; D011288:Prekallikrein